Episode Details
Back to Episodes
Teplizumab Delays Type 1 Diabetes Onset
Description
The NHS just approved teplizumab — a revolutionary therapy that can delay the onset of type 1 diabetes by up to three years, offering kids and families precious time before managing the condition. This immune-modulating treatment reprograms the body to stop attacking insulin-producing cells, turning symptom management into a proactive intervention. With ongoing studies like Elsa and T1DRA focusing on early screening, this breakthrough marks a major leap toward potentially preventing type 1 diabetes altogether — a game-changing win for the entire community.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/0302f87dba802019